title: Probing a chemical space for fragmental topology-activity landscapes (FRAGTAL): application for diketo acid and catechol HIV integrase inhibitor offspring fragments.
abstract: Fragmental topology-activity landscapes (FRAGTAL), a new concept for encoding molecular descriptors for fragonomics into the framework of the molecular database records is presented in this paper. Thus, a structural repository containing biological activity data was searched in a substructure mode by a series of molecular fragments constructed in an incremental or decremental manner. The resulted series of database hits annotated with their activities construct FRAGTAL descriptors encoding a frequency of the certain fragments among active compounds and/or their activities. Actually, this method might be interpreted as a simplified adaptation of the frequent subgraph mining (FSM) method. The FRAGTAL method reconstructs the way in which medicinal chemists are used to designing a prospective drug structure intuitively. A representative example of the practical application of FRAGTAL within the ChemDB Anti-HIV/OI/TB database for disclosing new fragments for HIV-1 integrase inhibition is discussed. In particular, FRAGTAL method identifies ethyl malonate amide (EMA) as the diketo acid (DKA) related arrangement. Since new molecular constructs based on the EMA fragment are still a matter of future investigations we referred to this as anthe DKA offspring.
authors: Department of Organic Chemistry, Institute of Chemistry, University of Silesia, PL-40-006 Katowice, Poland. abak@us.edu.pl
authors: Andrzej
authors: A
authors: Bak
authors: Tomasz
authors: T
authors: Magdziarz
authors: Agata
authors: A
authors: Kurczyk
authors: Katarzyna
authors: K
authors: Serafin
authors: Jaroslaw
authors: J
authors: Polanski
mesh_terms: D002396:Catechols / Q000737:chemistry / Q000494:pharmacology*; D062126:Databases, Chemical; D015195:Drug Design; D019427:HIV Integrase / Q000378:metabolism*; D019428:HIV Integrase Inhibitors / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology; D007651:Keto Acids / Q000737:chemistry / Q000494:pharmacology*; D008024:Ligands; D015394:Molecular Structure
chemical_list: D002396:Catechols; D019428:HIV Integrase Inhibitors; D007651:Keto Acids; D008024:Ligands; D019427:HIV Integrase; C034221:catechol